bioRxivBiophysics
Preparation and Characterization of Inactivated Tick-Borne Encephalitis Virus Samples for Single Particle Imaging at European XFEL
M. F. Vorovitch, V. R. Samygina, E. Pichkur, P. V. Konarev, G. Peters, E. V. Khvatov, A. L. Ivanova, K. K. Tuchynskaya, O. I. Konyushko, A. Y. Fedotov, G. Armeev, K. V. Shaytan, F. R. N. C. Maia, M. V. Kovalchuk, D. I. Osolodkin, A. A. Ishmukhametov, A. M. Egorov
Abstract
X-ray imaging of virus particles at European XFEL could eventually allow solving their complete structure, potentially approaching resolution of other structural virology methods. To achieve this ambitious goal with todays technologies, several mL of purified virus suspension containing at least 1012 particles per mL are required. Such large amounts of concentrated suspension have never before been obtained for enveloped viruses. Tick-borne encephalitis virus (TBEV) represents an attractive model system for the development of enveloped virus purification and concentration protocols, given the availability of large amounts of inactivated virus material provided by vaccine manufacturing facilities. Here we present the development of a TBEV vaccine purification and concentration scheme combined with a quality control protocol allowing substantial amounts of highly concentrated non-aggregated suspension to be obtained. Preliminary single particle imaging experiments were performed for this sample at European XFEL, showing distinct diffraction patterns.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The structure of immature tick-borne encephalitis virus
M. Anastasina, T. Fuzik, … S. J. Butcher·bioRxiv·Aug 4, 2023
- Development of a tick-borne encephalitis virus nanoparticle vaccine utilizing envelope dimer
Bingjie Wang, Haiyan Zhao·bioRxiv·Nov 13, 2024
- Low-pathogenic virus induced immunity against TBEV protects mice from disease but not from virus entry into the CNS
M. Petry, M. Palus, … C. Prajeeth·bioRxiv·Jan 11, 2021
- Comparison candidate Tick-borne encephalitis virus vaccines based on mRNA, adenovirus serotype 25 and chimera of YFV vaccine strain
Nadezhda A. Kuznetsova, Vladimir А. Gushchin, … Alexander L. Gintsburg·bioRxiv·Jan 16, 2025
- The influence of the pre-membrane and envelope proteins on structure, pathogenicity and tropism of tick-borne encephalitis virus
Ebba Rosendal, Kyrylo Bisikalo, … Anna K. Överby·Journal of VirologyPeer-reviewed·Aug 19, 2025
- Structural insights into tick-borne encephalitis virus neutralization and animal protection by a therapeutic antibody
I. K. Baykov, G. Chojnowski, … N. V. Tikunova·bioRxiv·Jul 28, 2021